Drug Shortage Report for MYCOPHENOLATE MOFETIL FOR INJECTION USP

Last updated on 2024-02-07 History
Report ID 207582
Drug Identification Number 02479974
Brand name MYCOPHENOLATE MOFETIL FOR INJECTION USP
Common or Proper name MYCOPHENOLATE MOFETIL FOR INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) MYCOPHENOLATE MOFETIL
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size PACK OF 4 VIALS
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-12-15
Actual start date
Estimated end date 2024-02-01
Actual end date 2024-02-06
Shortage status Resolved
Updated date 2024-02-07
Company comments Product is on 50% allocation at McKesson for all provinces.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-02-07 English Compare
v8 2024-02-06 French Compare
v7 2024-02-06 English Compare
v6 2024-01-22 French Compare
v5 2024-01-22 English Compare
v4 2023-12-16 English Compare
v3 2023-10-20 French Compare
v2 2023-10-20 English Compare
v1 2023-10-20 English Compare

Showing 1 to 9 of 9